These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 19477910)

  • 61. RAGE expression in the human peritoneal membrane.
    Kihm LP; Wibisono D; Müller-Krebs S; Pfisterer F; Morath C; Gross ML; Morcos M; Seregin Y; Bierhaus A; Nawroth PP; Zeier M; Schwenger V
    Nephrol Dial Transplant; 2008 Oct; 23(10):3302-6. PubMed ID: 18477569
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Expression and characterization of recombinant C-terminal biotinylated extracellular domain of human receptor for advanced glycation end products (hsRAGE) in Escherichia coli.
    Kumano-Kuramochi M; Xie Q; Sakakibara Y; Niimi S; Sekizawa K; Komba S; Machida S
    J Biochem; 2008 Feb; 143(2):229-36. PubMed ID: 18032414
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Calcium-regulated intramembrane proteolysis of the RAGE receptor.
    Galichet A; Weibel M; Heizmann CW
    Biochem Biophys Res Commun; 2008 May; 370(1):1-5. PubMed ID: 18355449
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Molecular effects of advanced glycation end products on cell signalling pathways, ageing and pathophysiology.
    Nedić O; Rattan SI; Grune T; Trougakos IP
    Free Radic Res; 2013 Aug; 47 Suppl 1():28-38. PubMed ID: 23692178
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The multiple faces of RAGE--opportunities for therapeutic intervention in aging and chronic disease.
    Ramasamy R; Shekhtman A; Schmidt AM
    Expert Opin Ther Targets; 2016; 20(4):431-46. PubMed ID: 26558318
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Implication of receptor for advanced glycation end product (RAGE) in pulmonary health and pathophysiology.
    Mukherjee TK; Mukhopadhyay S; Hoidal JR
    Respir Physiol Neurobiol; 2008 Aug; 162(3):210-5. PubMed ID: 18674642
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units.
    Dattilo BM; Fritz G; Leclerc E; Kooi CW; Heizmann CW; Chazin WJ
    Biochemistry; 2007 Jun; 46(23):6957-70. PubMed ID: 17508727
    [TBL] [Abstract][Full Text] [Related]  

  • 68. RAGE regulation and signaling in inflammation and beyond.
    Kierdorf K; Fritz G
    J Leukoc Biol; 2013 Jul; 94(1):55-68. PubMed ID: 23543766
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia.
    van Zoelen MA; Schouten M; de Vos AF; Florquin S; Meijers JC; Nawroth PP; Bierhaus A; van der Poll T
    J Immunol; 2009 Apr; 182(7):4349-56. PubMed ID: 19299735
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The RAGE pathway: activation and perpetuation in the pathogenesis of diabetic neuropathy.
    Lukic IK; Humpert PM; Nawroth PP; Bierhaus A
    Ann N Y Acad Sci; 2008 Apr; 1126():76-80. PubMed ID: 18448798
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Suppressed RAGE.
    Leslie M
    Sci Aging Knowledge Environ; 2004 Aug; 2004(31):nf71. PubMed ID: 15295105
    [No Abstract]   [Full Text] [Related]  

  • 72. Soluble forms of RAGE in internal medicine.
    Vazzana N; Santilli F; Cuccurullo C; Davì G
    Intern Emerg Med; 2009 Oct; 4(5):389-401. PubMed ID: 19727582
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Plasmatic isoforms of cytokeratin 18 and RAGE after severe trauma: a longitudinal cohort study.
    Uhle F; Nouland Dv; Little S; Menges T; Weiterer S; Szalay G; Franke J; Schnettler R; Weigand MA; Lichtenstern C
    J Trauma Acute Care Surg; 2014 Oct; 77(4):577-84. PubMed ID: 25250597
    [TBL] [Abstract][Full Text] [Related]  

  • 74. RAGE splicing variants in mammals.
    Sterenczak KA; Nolte I; Murua Escobar H
    Methods Mol Biol; 2013; 963():265-76. PubMed ID: 23296616
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluation of rage isoforms, ligands, and signaling in the brain.
    Ding Q; Keller JN
    Biochim Biophys Acta; 2005 Oct; 1746(1):18-27. PubMed ID: 16214242
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Solution structure of the soluble receptor for advanced glycation end products (sRAGE).
    Sárkány Z; Ikonen TP; Ferreira-da-Silva F; Saraiva MJ; Svergun D; Damas AM
    J Biol Chem; 2011 Oct; 286(43):37525-34. PubMed ID: 21865159
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Assay validation and biological variation of serum receptor for advanced glycation end-products.
    Brown LF; Fraser CG
    Ann Clin Biochem; 2008 Sep; 45(Pt 5):518-9. PubMed ID: 18753428
    [TBL] [Abstract][Full Text] [Related]  

  • 78. RAGE and RAGE ligands in cancer.
    Logsdon CD; Fuentes MK; Huang EH; Arumugam T
    Curr Mol Med; 2007 Dec; 7(8):777-89. PubMed ID: 18331236
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders.
    Hudson BI; Bucciarelli LG; Wendt T; Sakaguchi T; Lalla E; Qu W; Lu Y; Lee L; Stern DM; Naka Y; Ramasamy R; Yan SD; Yan SF; D'Agati V; Schmidt AM
    Arch Biochem Biophys; 2003 Nov; 419(1):80-8. PubMed ID: 14568011
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparison of distinct protein isoforms of the receptor for advanced glycation end-products expressed in murine tissues and cell lines.
    Gefter JV; Shaufl AL; Fink MP; Delude RL
    Cell Tissue Res; 2009 Jul; 337(1):79-89. PubMed ID: 19415334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.